a nca disease: pathology
DESCRIPTION
A NCA disease: pathology. D ušan F erluga Institute of Pathology, Faculty of Medicine, University of Ljubljana Ljubljana, Slovenia. S ystemic vasculitides. International Consensus Conference , Chapel Hill, USA, 1993 ( proposal in Arthritis&Rheumatism 1994, 37: 187-192) - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/1.jpg)
AANCANCA disease: disease: pathologypathology
Dušan Ferluga
Institute of Pathology, Faculty of Medicine, University of Ljubljana
Ljubljana, Slovenia
![Page 2: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/2.jpg)
SSystemic vasculitidesystemic vasculitides
International Consensus Conference, Chapel Hill, USA, 1993
(proposal in Arthritis&Rheumatism 1994, 37: 187-192)
- Terminology (names of diseases = diagnostic terms)- Definition of diseases (abnormalities that warrant
assignement of the diagnostic terms)- Diagnostic criteria? (not yet defined)
![Page 3: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/3.jpg)
![Page 4: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/4.jpg)
Small vessel vasculitidesSmall vessel vasculitides
• Frequent affection of kidneys (up to 100%)Glomerulonephritis, extraglomerular vasculitis, tubulointerstitial involvement
• Important contribution of kidney biopsy to establish diagnosis and to evaluate activity, chronicity and severity (extent)
• Final diagnosis clinical (immunoserology!)-pathological
![Page 5: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/5.jpg)
NeNecrotizingcrotizing crescentic crescentic glomerulonephritisglomerulonephritis (NC-GN) (NC-GN)
• Focal (<50%) or diffuse (>50%)
• Isolated (primary), in systemic vasculitides, in autoimmune connective tissuee diseases
• Immunopathogenetic categories:1. Immune complex NC-GN 98/285 – 34,4%2. Anti-GBM NC-GN 40/285 – 14,0% 3. Pauci-immune ANCA NC-GN 147/285 – 51,6%
![Page 6: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/6.jpg)
![Page 7: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/7.jpg)
![Page 8: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/8.jpg)
![Page 9: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/9.jpg)
![Page 10: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/10.jpg)
Significance of kidney biopsy in Significance of kidney biopsy in ANCA diseaseANCA disease
To confirm diagnosis - why?
ANCA specificity and sensitivity are not absolute. Not all ANCA positive patients have ANCA vasculitis and ANCA negative results do not exclude ANCA disease.
![Page 11: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/11.jpg)
Histopathologic hallmarks of Histopathologic hallmarks of ANCA glomerulonephritis / ANCA glomerulonephritis /
vasculitisvasculitis
• Pauci-immune pattern by immunofluorescence• Fibrinoid necrosis• Extracapillary crescents without significant
glomerular proliferation• Residual scarring glomerulosclerosis
(segmental, global)
![Page 12: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/12.jpg)
![Page 13: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/13.jpg)
![Page 14: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/14.jpg)
![Page 15: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/15.jpg)
![Page 16: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/16.jpg)
CD68
![Page 17: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/17.jpg)
![Page 18: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/18.jpg)
![Page 19: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/19.jpg)
Clinico-pathologic diagnosis in Clinico-pathologic diagnosis in 135 patients with ANCA renal disease135 patients with ANCA renal disease
Diagnosis PR3-ANCA
(n=55)
MPO-ANCA
(n=74)
Other ANCA antigens
(n=6)
Wegener’s granulomatosis 47/56 8/56 1/56
Microscopic polyangiitis
6/50 42/50 2/50
Renal limited vasculitis 2/28 23/28 3/28
Churg Strauss syndrome 0/1 1/1 0/1
![Page 20: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/20.jpg)
Significance of kidney biopsy in Significance of kidney biopsy in differential diagnosis of ANCA differential diagnosis of ANCA
vasculitidesvasculitides
• Underdiagnosed extraglomerular focal necrotizing vasculitis (5 - 35%), suggesting systemic vasculitides, because of biopsy sampling inspite of serial sections
• Limited significance of kidney biopsy in distinguishing between MPA, WG and CS (limited specificities of eosinophilic infiltration, absence of true interstitial geographic type granulomas as typically seen in respiratory tract)
![Page 21: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/21.jpg)
![Page 22: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/22.jpg)
![Page 23: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/23.jpg)
![Page 24: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/24.jpg)
![Page 25: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/25.jpg)
![Page 26: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/26.jpg)
Renal histologic changes in 135 patients Renal histologic changes in 135 patients with ANCA-associated GNwith ANCA-associated GN
Histologic changes
PR3-ANCA
(n=55)
MPO-ANCA
(n=74)
Other ANCA antigens
(n=6)
GN focal - diffuse 31 - 24* 18 - 56* 4 - 2
Glom necrosis 1.8 ± 1.3* 1.3 ± 1.2* 0.8 ± 0.9
Glom exud react 1.2 ± 1.2 0.8 ± 0.9 0.5 ± 0.8
Crescents 38.5% 43.6% 37.5%
Glob GSCL 11.5%* 24.0%* 17.7%
Seg GSCL 7.0%* 13.9%* 4.2%
Interst fibrosis 1.3 ± 1.1* 2.2 ± 1.2* 2.2 ± 1.0•P<0.05Vizjak A et al. Am J K id Dis 2003
![Page 27: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/27.jpg)
Selected demographic and clinical data Selected demographic and clinical data of 135 patients with ANCA-associated GNof 135 patients with ANCA-associated GN
Feature PR3-ANCA
(n=55)
MPO-ANCA
(n=74)
Other ANCA antigens
(n=6)
Age (years) 55.9* 63.3* 63.2*
Male/female 33/22 22/52 2/4
Serum creatinine (µmol/L)
368.9 455.9 361.3
Duration of disease (months)
14.8 8.5 16.8
Duration of renal disease (months)
3.0* 6.9* 3.6
*P<0.05
Vizjak et al. Am J Kid Dis 2003
![Page 28: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/28.jpg)
Comparison of histologic changes in the Comparison of histologic changes in the first renal biopsy and rebiopsies of 38 first renal biopsy and rebiopsies of 38
patients with ANCA vasculitispatients with ANCA vasculitisHistologic changes First renal
biopsy (n = 38)
Rebiopsies
(n = 45)
Pvalue
GN - active 11 (28.9%) 0 <0.005
- active/chronic 24 (63.2%) 16 (35.6%) <0.005
- chronic 3 (7.9%) 29 (64.4%) <0.005
Glom necrosis 1.7 ± 1.1 0.3 ± 0.6 <0.005
Extracap crescents 47.2 ± 24.1 18.6 ± 23.7 <0.005
Glob GSCL 15.7 ± 15.4 39.2 ± 23.9 <0.005
Seg GSCL 9.2 ± 10.2 15.2 ± 12.3 0.016
Interstitial fibrosis 1.8 ± 1.3 2.6 ± 1.1 0.004
![Page 29: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/29.jpg)
Significance of kidney biopsy in ANCA Significance of kidney biopsy in ANCA diseasedisease
• Major significance for planning therapy, monitoring response and detecting recurrences.
Pathologist has to provide exact information – quantitative data about active therapeutically accesible lesions (necrotizing, crescentic), about irreversible chronic sclerotic changes, as well as about preserved nephrons.
![Page 30: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/30.jpg)
Classification schema for ANCA-associated glomerulonephritis
Class Inclusion Criteria
Focal ≥50% normal glomeruli
Crescentic ≥50% glomeruli with cellular crescents
Mixed <50% normal, <50% crescentic, <50% globally sclerotic glomeruli
Sclerotic ≥50% globally sclerotic glomeruli
Pauci-immune staining pattern on immunofluorescence microscopy (IM) and ≥1 glomerulus with necrotizing or crescentic glomerulonephritis on light microscopy (LM) are required for inclusion in all four classes.
(Berden, AE et al. JASN 2010; 21: 1628-36)
![Page 31: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/31.jpg)
Biopsy report schema for ANCA glomerulonephritis (GN)Biopsy report schema for ANCA glomerulonephritis (GN)
1. Focal (≤50%; indicating percentage of normal glomeruli)
1.1. Focal active (A): necrosis (%), crescents (%: cellular, fibrocellular)1.2. Focal chronic (C): sclerosis – global (%), segmental (%), crescents (%: fibrous)1.3. Focal active and chronic (A/C): as in 1.1+1.2. 2. Diffuse (≥50%; indicating percentage of normal glomeruli)2.1. Diffuse active (A): necrosis (%), crescents (%: cellular, fibrocellular)2.2. Diffuse chronic (C): sclerosis – global (%), segmental (%), crescents (%: fibrous)2.3. Diffuse active and chronic (A/C): as in 2.1+2.2
____________________________________________________________________
*Inclusion criteria: pauci-immune GN and ≥1 glomerulus with necrosis and/or crescent (cellular, fibrocellular, fibrous) in all six classes____________________________________________________________________
(Ferluga D. et al. 1st MCP, Ohrid 2011)
![Page 32: A NCA disease: pathology](https://reader036.vdocuments.us/reader036/viewer/2022062410/56815a8e550346895dc804ab/html5/thumbnails/32.jpg)
Collaborators and Collaborators and contributorscontributors
Alenka Vizjak (immunopathology)
Anastazija Hvala (electron microscopy)
Jelka Lindič (nephrology)